Allogeneic Cell Therapy Global Market Report 2025

Description

Allogeneic cell therapy involves harvesting cells from a donor to treat a recipient. Its purpose is to replace or repair damaged tissues, modulate immune responses, or address conditions such as cancer, genetic disorders, and autoimmune diseases.

There are two main types of allogeneic cell therapy stem cell therapies and non-stem cell therapies. Stem cell therapies use stem cells to repair or replace damaged tissues or organs, aiming to prevent or treat a range of diseases and conditions. These therapies are applied in various medical fields, including hematological disorders, dermatological disorders, and other therapeutic areas, utilized by hospitals, specialty clinics, and research organizations.

The allogenic cell therapy market research report is one of a series of new reports from The Business Research Company that provides allogenic cell therapy market statistics, including allogenic cell therapy industry global market size, regional shares, competitors with a allogenic cell therapy market share, detailed allogenic cell therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the allogenic cell therapy industry. This allogenic cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The allogeneic cell therapy market size has grown rapidly in recent years. It will grow from $1.08 billion in 2024 to $1.2 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to an increased focus on tailoring donor cell selection and genetic modifications, increased population, increase in the global burden of chronic diseases, increased awareness, and increase in the number of collaborations for biosimilar development.

The allogeneic cell therapy market size is expected to see rapid growth in the next few years. It will grow to $1.86 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to the increasing need for advanced medical treatments, growing demand for novel allogeneic cell therapies, rising number of clinical trials, growing patient population contributions, and rising income levels. Major trends in the forecast period include technology advancements, partnerships, big companies collaborating with others, merger and acquisitions, new product launch.

The rise in chronic diseases is expected to propel the expansion of the allogeneic cell therapy market. Chronic illnesses, characterized by prolonged duration and necessitating continual medical care, can impede daily functioning and diminish life quality. These conditions' prevalence stems from altered lifestyle habits, genetic inheritance, and exposure to environmental toxins and pollutants. Allogeneic cell therapy offers substantial promise in addressing a broad spectrum of chronic diseases, utilizing healthy donor cells to repair, substitute, or regulate dysfunctional recipient cells or tissues. For example, a report from the National Center for Biotechnology Information (NCBI) projected a 99.5% increase in individuals aged 50 and above suffering from one or more chronic ailments by 2050, rising from 71.52 million in 2020 to 142.66 million. Consequently, the escalating occurrence of chronic diseases propels the allogeneic cell therapy market's growth.

Key players in the allogeneic cell therapy sector are concentrating on pioneering solutions, such as cell processing platforms, to fortify their market standing. These platforms encompass systems and technologies employed in preparing and manipulating cells for therapeutic purposes, including isolation, purification, expansion, modification, and quality assurance to ensure clinical suitability. For instance, in March 2024, Getinge, a Swedish healthcare entity, collaborated with CellRev, a UK biotech firm, to introduce Livit ACE, a continuous cell processing platform for Adherent Cell Expansion (ACE). This cutting-edge platform integrates advanced automation and bioprocessing technologies, markedly augmenting cell production efficiency and scalability. Notable features include top-tier cell isolation and purification systems ensuring high purity and viability, robust expansion capabilities for generating ample therapeutic cells, advanced genetic modification tools for precise cell engineering, and stringent quality control protocols to ensure product safety and efficacy.

In February 2024, AstraZeneca, a UK-based pharmaceutical company specializing in oncology and rare diseases, acquired Gracell Biotechnologies for an undisclosed amount. This strategic acquisition allows AstraZeneca to enhance its portfolio in oncology and rare diseases by integrating Gracell Biotechnologies' advanced cell therapy capabilities. Gracell's expertise in allogeneic cell therapy could accelerate the development of innovative treatments for challenging cancers and other serious conditions. Gracell Biotechnologies, based in China, is recognized for its pioneering work in cell therapy, aiming to revolutionize the treatment landscape for various cancers and rare diseases.

Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, TrakCel Ltd., Promab Biotechnologies Inc., Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Minerva Biotechnologies Corporation, Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG

North America was the largest region in the allogeneic cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the allogeneic cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The allogeneic cell therapy market includes revenues earned by entities through induced pluripotent stem cell therapy, hematopoietic stem cell transplantation, mesenchymal stem cell (MSC) therapy, induced pluripotent stem cell (IPSC) therapy and chimeric antigen receptor T cell therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Allogeneic Cell Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allogeneic cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for allogeneic cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The allogeneic cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Stem Cell Therapies; Non-Stem Cell Therapies
2) By Therapeutic Area: Hematological Disorders; Dermatological Disorders; Other Therapeutic Area
3) By End User: Hospitals; Specialty Clinics; Research Organizations
Subsegments:
1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells); Mesenchymal Stem Cell Therapy (MSC-Based Therapies); Induced Pluripotent Stem Cells (iPSC-Based Therapies); Neural Stem Cell Therapy; Other Stem Cell Therapies
2) By Non-Stem Cell Therapies: T-cell Therapies; Natural Killer (NK) Cell Therapies; Dendritic Cell Therapies; Other Non-Stem Cell Therapies
Companies Mentioned: Novartis AG; Bristol Myers Squibb Company; Takeda Pharmaceutical Company Limited; Bluebird Bio Inc.; Poseida Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29384

1. Executive Summary

2. Allogeneic Cell Therapy Market Characteristics

3. Allogeneic Cell Therapy Market Trends And Strategies

4. Allogeneic Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Allogeneic Cell Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Allogeneic Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Allogeneic Cell Therapy Market Growth Rate Analysis
5.4. Global Allogeneic Cell Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Allogeneic Cell Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Allogeneic Cell Therapy Total Addressable Market (TAM)

6. Allogeneic Cell Therapy Market Segmentation

6.1. Global Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stem Cell Therapies
Non-Stem Cell Therapies
6.2. Global Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematological Disorders
Dermatological Disorders
Other Therapeutic Area
6.3. Global Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Research Organizations
6.4. Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Stem Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematopoietic Stem Cell Therapy
Mesenchymal Stem Cell Therapy
Induced Pluripotent Stem Cells
Neural Stem Cell Therapy
Other Stem Cell Therapies
6.5. Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Non-Stem Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
T-cell Therapies
Natural Killer (NK) Cell Therapies
Dendritic Cell Therapies
Other Non-Stem Cell Therapies

7. Allogeneic Cell Therapy Market Regional And Country Analysis

7.1. Global Allogeneic Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Allogeneic Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Allogeneic Cell Therapy Market

8.1. Asia-Pacific Allogeneic Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Allogeneic Cell Therapy Market

9.1. China Allogeneic Cell Therapy Market Overview
9.2. China Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Allogeneic Cell Therapy Market

10.1. India Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Allogeneic Cell Therapy Market

11.1. Japan Allogeneic Cell Therapy Market Overview
11.2. Japan Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Allogeneic Cell Therapy Market

12.1. Australia Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Allogeneic Cell Therapy Market

13.1. Indonesia Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Allogeneic Cell Therapy Market

14.1. South Korea Allogeneic Cell Therapy Market Overview
14.2. South Korea Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Allogeneic Cell Therapy Market

15.1. Western Europe Allogeneic Cell Therapy Market Overview
15.2. Western Europe Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Allogeneic Cell Therapy Market

16.1. UK Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Allogeneic Cell Therapy Market

17.1. Germany Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Allogeneic Cell Therapy Market

18.1. France Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Allogeneic Cell Therapy Market

19.1. Italy Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Allogeneic Cell Therapy Market

20.1. Spain Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Allogeneic Cell Therapy Market

21.1. Eastern Europe Allogeneic Cell Therapy Market Overview
21.2. Eastern Europe Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Allogeneic Cell Therapy Market

22.1. Russia Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Allogeneic Cell Therapy Market

23.1. North America Allogeneic Cell Therapy Market Overview
23.2. North America Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Allogeneic Cell Therapy Market

24.1. USA Allogeneic Cell Therapy Market Overview
24.2. USA Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Allogeneic Cell Therapy Market

25.1. Canada Allogeneic Cell Therapy Market Overview
25.2. Canada Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Allogeneic Cell Therapy Market

26.1. South America Allogeneic Cell Therapy Market Overview
26.2. South America Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Allogeneic Cell Therapy Market

27.1. Brazil Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Allogeneic Cell Therapy Market

28.1. Middle East Allogeneic Cell Therapy Market Overview
28.2. Middle East Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Allogeneic Cell Therapy Market

29.1. Africa Allogeneic Cell Therapy Market Overview
29.2. Africa Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Allogeneic Cell Therapy Market Competitive Landscape And Company Profiles

30.1. Allogeneic Cell Therapy Market Competitive Landscape
30.2. Allogeneic Cell Therapy Market Company Profiles
- 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bluebird Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Poseida Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Allogeneic Cell Therapy Market Other Major And Innovative Companies

31.1. Fate Therapeutics Inc.
31.2. Fortress Biotech Inc.
31.3. Sorrento Therapeutics Inc.
31.4. Eureka Therapeutics Inc.
31.5. Juno Therapeutics Inc.
31.6. Adaptimmune Therapeutics plc
31.7. Cellectis SA
31.8. TrakCel Ltd.
31.9. Promab Biotechnologies Inc.
31.10. Ziopharm Oncology Inc.
31.11. Allogene Therapeutics Inc.
31.12. Century Therapeutics Inc.
31.13. Autolus Therapeutics plc
31.14. Bellicum Pharmaceuticals Inc.
31.15. Minerva Biotechnologies Corporation

32. Global Allogeneic Cell Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allogeneic Cell Therapy Market

34. Recent Developments In The Allogeneic Cell Therapy Market

35. Allogeneic Cell Therapy Market High Potential Countries, Segments and Strategies

35.1 Allogeneic Cell Therapy Market In 2029 - Countries Offering Most New Opportunities
35.2 Allogeneic Cell Therapy Market In 2029 - Segments Offering Most New Opportunities
35.3 Allogeneic Cell Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer